≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

6-mercaptopurine

Endpoint Browser

RX_L01BB02

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Medicine purchases: ATC — L01BB02

1 out of 7 registries used, show all original rules.

1232

4. Check minimum number of events

Min. number of events 3
1232

5. Include endpoints

None

1232

6. Filter based on genotype QC (FinnGen only)

1232

Control definitions (FinnGen only)

Control exclude
IBD_DRUGS

Extra metadata

First used in FinnGen datafreeze
DF4

Case counts by codes

↥

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 1232 700 532
Unadjusted period prevalence (%) 0.24 0.24 0.23
Median age at first event (years) 40.76 39.02 43.05

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
987
Matched controls
9869
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L04AX01
ATC
azathioprine; systemic
748.3
323.0
572
18
A07EC02
ATC
mesalazine; oral, rectal
683.8
323.0
665
30
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
238.1
323.0
381
26
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
2671.7
323.0
762
13
A07EA06
ATC
budesonide; oral, local oral
519.3
323.0
521
21
L01BB02
ATC
mercaptopurine; oral
+∞
323.0
987
*
UJF30
NOMESCO Finland
Ileoscopy through colon
33.1
323.0
490
285
K51.5
ICD-10 Finland
Left sided colitis
1082.3
323.0
466
8
H02AB06
ATC
prednisolone; systemic
27.3
323.0
852
1852
UJF32
NOMESCO Finland
Coloscopy
16.6
318.4
623
920
K51.3
ICD-10 Finland
Ulcerative (chronic) rectosigmoiditis
+∞
298.5
271
*
A07EA02
ATC
hydrocortisone; rectal
623.7
290.4
274
6
K50.8
ICD-10 Finland
Other Crohn disease
359.3
229.0
223
8
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
9.5
194.2
487
920
K50.0
ICD-10 Finland
Crohn disease of small intestine
217.6
191.7
193
11
K50.1
ICD-10 Finland
Crohn disease of large intestine
313.9
182.4
180
7
K50.9
ICD-10 Finland
Crohn disease, unspecified
185.5
178.4
182
12
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
2081.7
177.6
167
*
K51.8
ICD-10 Finland
Other ulcerative colitis
887.6
158.1
151
*
H02AB07
ATC
prednisone; oral
11.9
155.3
312
369
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
1713.3
153.3
145
*
K51.2
ICD-10 Finland
Ulcerative (chronic) proctitis
571.2
152.0
147
*
A07EC01
ATC
sulfasalazine; oral, rectal
36.5
133.8
173
57
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
19.6
131.0
205
130
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
225.1
117.4
119
6
ZX120
NOMESCO Finland
Intravenous
10.9
116.1
239
281
K51
ICD-10 Finland
Ulcerative colitis
558.9
103.6
101
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
19.3
102.3
160
98
L04AB04
ATC
adalimumab; parenteral
101.0
99.3
108
12
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
4.7
90.1
387
1195
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.1
88.2
485
1885
H02AB09
ATC
hydrocortisone; systemic
22.1
83.0
123
63
K51.0
ICD-10 Finland
Ulcerative (chronic) pancolitis
+∞
79.2
75
*
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
217.3
78.5
80
*
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
155.1
68.9
72
5
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
11.5
66.1
128
126
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
87.6
66.0
73
9
J01MA02
ATC
ciprofloxacin; systemic
3.4
65.4
435
1848
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
7.5
64.7
163
253
A02BC02
ATC
pantoprazole; systemic
3.2
64.4
662
3833
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
6.5
61.9
175
318
O99.6
ICD-10 Finland
Diseases of the digestive system complicating pregnancy, childbirth and the puerperium
52.4
61.2
73
15
D94
ICPC
Chronic enteritis/ulcerative colitis
327.3
61.1
61
*
UJF92
NOMESCO Finland
Capsular endoscopy
20.0
61.0
93
51
TPH04
NOMESCO Finland
Cathetrisation of vein
4.0
60.7
286
905
WX002
NOMESCO Finland
Sedation and analgesia
4.2
60.2
266
793
P01AB01
ATC
metronidazole; oral, rectal
3.0
56.5
482
2372
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
11.3
54.1
105
103
XW000
NOMESCO Finland
Bone marrow biopsy
12.0
53.1
100
92
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
19.5
49.7
76
42
4AA12
NOMESCO Finland
NA
+∞
49.4
47
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
15.5
47.4
79
55
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
479.4
46.7
46
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.0
46.5
208
612
JF1DG
NOMESCO Finland
Small bowel very extensive MRI with with high intensity magnet
246.4
46.4
47
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
8.2
44.7
104
140
TAB00
NOMESCO Finland
Lumbar puncture
7.0
42.1
109
172
4AB02
NOMESCO Finland
NA
+∞
42.0
40
*
L04AC05
ATC
ustekinumab; parenteral
219.1
41.2
42
*
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
413.7
40.4
40
*
A05AA02
ATC
ursodeoxycholic acid; oral
18.5
39.3
61
35
Z85.6
ICD-10 Finland
Personal history of leukaemia
208.2
39.1
40
*
L04AD01
ATC
ciclosporin; systemic
17.4
37.2
59
36
K50
ICD-10 Finland
Crohn disease [regional enteritis]
197.4
37.0
38
*
A07EA01
ATC
prednisolone; rectal
128.0
34.9
37
*
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
52.0
33.7
40
8
M07.5*K51.9
ICD-10 Finland
Arthropathy in ulcerative colitis
+∞
32.5
31
*
L04AB06
ATC
golimumab; parenteral
88.0
30.9
34
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
9.8
30.8
63
68
R50.9
ICD-10 Finland
Fever, unspecified
3.1
30.5
192
719
3005
Kela drug reimbursment
Tofacitinib
+∞
30.4
29
*
K75.4
ICD-10 Finland
Autoimmune hepatitis
311.5
30.0
30
*
WVA20
NOMESCO Finland
Medicine administration
13.4
29.1
51
40
JF1BD
NOMESCO Finland
Very extensive small bowel CT
68.1
29.1
33
5
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.7
28.8
135
403
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
50.2
28.6
34
7
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
12.8
28.0
50
41
ZX131
NOMESCO Finland
Intrathecal
289.3
27.9
28
*
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
6.6
27.2
72
117
M07.4*K50.9
ICD-10 Finland
Arthropathy in Crohn's disease [regional enteritis]
278.3
26.8
27
*
A06AC01
ATC
ispaghula (psylla seeds); oral
2.6
26.6
223
991
WW500
NOMESCO Finland
Blood transfusion
6.7
26.6
69
109
H02AB04
ATC
methylprednisolone; systemic
3.4
26.5
142
471
L04AA29
ATC
tofacitinib; oral
+∞
26.2
25
*
C10AC01
ATC
colestyramine; oral
10.1
26.0
52
54
J05AB11
ATC
valaciclovir; oral
3.1
25.9
156
563
A07EC03
ATC
olsalazine; oral
+∞
25.1
24
*
253
Kela drug reimbursment
NA
+∞
24.1
23
*
3042
Kela drug reimbursment
NA
+∞
24.1
23
*
9811/3-C42.1
ICD-O-3
B lymphoblastic leukemia/lymphoma, NOS, of bone marrow
245.7
23.7
24
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.1
23.4
379
2287
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
25.4
23.2
32
13
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
4.5
22.9
84
200
H02AB02
ATC
dexamethasone; systemic
3.4
22.6
116
371
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
8.1
22.5
51
66
J01MA12
ATC
levofloxacin; systemic
2.8
22.3
161
649
WX302
NOMESCO Finland
Thoracal epidural anesthesy
5.0
22.2
73
155
C92.4
ICD-10 Finland
Acute promyelocytic leukaemia [PML]
+∞
22.0
21
*
3AC01
NOMESCO Finland
NA
17.6
21.9
34
20
K83.0
ICD-10 Finland
Cholangitis
18.9
21.8
33
18
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
21.7
268
1430
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.4
21.2
79
191
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
9.2
21.0
44
50
N02AX02
ATC
tramadol; systemic, rectal
2.0
20.5
351
2137
WW200
NOMESCO Finland
Immunization
5.9
19.9
56
99
1XX02
NOMESCO Finland
NA
+∞
19.9
19
*
JFH30
NOMESCO Finland
Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy
+∞
19.9
19
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.3
19.8
218
1097
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
56.2
19.0
22
*
K76.9
ICD-10 Finland
Liver disease, unspecified
13.7
18.8
32
24
5561A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) ileocolitis
+∞
18.8
18
*
N02BE01
ATC
paracetamol; systemic, rectal
2.0
18.7
780
6442
JFG00
NOMESCO Finland
Closure of loop enterostomy without resection
39.2
18.6
23
6
D64.9
ICD-10 Finland
Anaemia, unspecified
3.7
18.5
82
233
A04AA01
ATC
ondansetron; systemic, rectal
3.8
18.1
80
226
A41.9
ICD-10 Finland
Sepsis, unspecified
6.1
17.9
49
84
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
14.0
17.8
30
22
C05AA08
ATC
fluocortolone; rectal, topical
2.6
17.8
138
574
TPX10
NOMESCO Finland
Implantation of vascular injection port
6.2
17.7
48
81
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
183.1
17.6
18
*
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.6
16.9
59
134
4AA33
NOMESCO Finland
NA
+∞
16.7
16
*
ZX114
NOMESCO Finland
Intramuscular
8.1
16.7
37
47
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
6.1
15.9
43
73
ZX121
NOMESCO Finland
Central venous catheter
26.8
15.6
21
8
M05BA04
ATC
alendronic acid; oral
4.9
15.3
50
106
L03AA02
ATC
filgrastim; parenteral
5.8
14.9
42
75
A02BC03
ATC
lansoprazole; oral
2.0
14.9
225
1280
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.7
14.8
404
2805
B03BA03
ATC
hydroxocobalamin; parenteral
4.8
14.8
49
106
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.4
14.7
138
636
2040A
ICD-9 Finland
Lymphoid leukaemia, Acute
+∞
14.6
14
*
JFH33
NOMESCO Finland
Total colectomy, mucosal proctectomy, ileoanal anastomosis and ileostomy
+∞
14.6
14
*
JFH11
NOMESCO Finland
Laparoscopic colectomy
+∞
14.6
14
*
JF1AD
NOMESCO Finland
Small bowel CT
27.6
14.3
19
7
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.1
14.2
190
1028
A07AA09
ATC
vancomycin; oral
14.7
14.1
23
16
A02BC05
ATC
esomeprazole; systemic
1.8
14.1
324
2125
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
9.0
14.0
29
33
XF400
NOMESCO Finland
ECG with 12 standard connections
2.3
13.7
134
627
J02AC01
ATC
fluconazole; systemic
1.7
13.6
360
2464
A02BC01
ATC
omeprazole; systemic
1.9
12.8
216
1272
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
6.1
12.8
34
57
M45
ICD-10 Finland
Ankylosing spondylitis
10.7
12.8
24
23
N02AJ06
ATC
codeine and paracetamol; systemic
1.7
12.8
337
2290
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
4.6
12.7
44
100
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
12.5
157
824
JFB20
NOMESCO Finland
Ileocaecal resection
20.3
12.5
18
9
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
8.6
12.3
26
31
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.9
12.3
77
284
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.8
12.2
224
1355
R74.0
ICD-10 Finland
Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]
6.5
12.2
31
49
UJF30
SPAT
NA
21.6
12.0
17
8
UJF12
NOMESCO Finland
Enteroscopy through intestinal stoma
47.3
11.9
14
*
B01AB05
ATC
enoxaparin; parenteral
1.8
11.9
218
1318
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
6.0
11.9
32
55
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
8.5
11.8
25
30
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
11.6
403
2938
JFB00
NOMESCO Finland
Partial resection of small intestine
9.4
11.5
23
25
K73.0
ICD-10 Finland
Chronic persistent hepatitis, not elsewhere classified
+∞
11.5
11
*
JGB50
NOMESCO Finland
Mucosal proctectomy and ileoanal anastomosis
+∞
11.5
11
*
56300
ICD-8 Finland
Chronic enteritis and ulcerative colitis, Regional enteritis
+∞
11.5
11
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.0
11.3
146
772
J01DB01
ATC
cefalexin; oral
1.7
11.3
769
6657
JN3AD
NOMESCO Finland
Abdominal CT examination
2.8
11.2
71
264
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.8
11.2
73
275
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
14.1
11.0
18
13
UJK02
NOMESCO Finland
ERCP
6.4
11.0
28
45
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
43.8
10.9
13
*
TGC00
NOMESCO Finland
Bronchial lavation
8.4
10.8
23
28
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
9.0
10.8
22
25
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
18.0
10.7
16
9
K03.66
ICD-10 Finland
Tooth plaque
2.6
10.7
81
332
A07DA03
ATC
loperamide; oral
4.9
10.6
34
72
A06AC51
ATC
ispaghula, combinations; systemic
3.4
10.6
51
157
K92.1
ICD-10 Finland
Melaena
3.7
10.5
45
126
J01FA09
ATC
clarithromycin; systemic
1.7
10.5
280
1888
J05AB01
ATC
aciclovir; systemic
1.8
10.5
182
1075
JFH10
NOMESCO Finland
Total colectomy and ileostomy
+∞
10.4
10
*
L01BB03
ATC
tioguanine; oral
+∞
10.4
10
*
K51.4
ICD-10 Finland
Inflammatory polyps
+∞
10.4
10
*
5562A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) proctitis
+∞
10.4
10
*
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
6.9
10.4
25
37
M04AA01
ATC
allopurinol; systemic
2.7
10.4
72
281
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
8.9
10.3
21
24
JFG20
NOMESCO Finland
Closure of enterostomy with resection of exteriorised loop
23.6
10.3
14
6
RD210
NOMESCO Finland
NA
4.5
10.0
34
77
K73.9
ICD-10 Finland
Chronic hepatitis, unspecified
20.3
9.8
14
7
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.7
9.8
41
113
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.7
9.8
41
113
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.9
9.7
60
219
56310
ICD-8 Finland
Chronic enteritis and ulcerative colitis, Ulcerative colitis
55.5
9.7
11
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
9.5
176
1059
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.3
9.4
34
82
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
101.0
9.4
10
*
JFH20
NOMESCO Finland
Proctocolectomy and ileostomy
101.0
9.4
10
*
ZX112
NOMESCO Finland
Subcutaneous
6.3
9.4
24
39
Z93.2
ICD-10 Finland
Ileostomy status
30.3
9.4
12
*
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
5.7
9.4
26
47
L03AA10
ATC
lenograstim; parenteral
+∞
9.4
9
*
2AX04
NOMESCO Finland
NA
+∞
9.4
9
*
L04AA33
ATC
vedolizumab; parenteral
+∞
9.4
9
*
5552A
ICD-9 Finland
Regional enteritis, Small intestine with large intestine
+∞
9.4
9
*
A01AB09
ATC
miconazole; local oral
2.5
9.3
75
319
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.6
9.3
266
1820
WX402
NOMESCO Finland
General anaesthesia
1.8
9.1
153
893
D06BX01
ATC
metronidazole; topical
2.2
9.1
92
439
WZC30
NOMESCO Finland
Teaching
2.1
9.1
103
516
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
10.2
9.0
17
17
K60.3
ICD-10 Finland
Anal fistula
4.9
9.0
28
58
M13.9
ICD-10 Finland
Arthritis, unspecified
2.9
9.0
54
195
B02.9
ICD-10 Finland
Zoster without complication
3.1
8.9
46
151
B81
ICPC
Anaemia vit B12/folate deficiency
4.6
8.8
29
64
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
10.8
8.8
16
15
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
4.8
8.8
28
60
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
3.1
8.8
47
158
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
6.5
8.5
21
33
B01AB10
ATC
tinzaparin; parenteral
2.7
8.5
55
209
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
5.7
8.5
23
41
5568X
ICD-9 Finland
Idiopathic proctocolitis, Other ulcerative colitis
90.8
8.4
9
*
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
90.8
8.4
9
*
M81.4
ICD-10 Finland
Drug-induced osteoporosis
90.8
8.4
9
*
M07.5
ICD-10 Finland
Arthropathy in ulcerative colitis
+∞
8.3
8
*
M07.4
ICD-10 Finland
Arthropathy in Crohn disease [regional enteritis]
+∞
8.3
8
*
5550A
ICD-9 Finland
Regional enteritis, Small intestine
+∞
8.3
8
*
M25.5
ICD-10 Finland
Pain in joint
1.6
8.3
230
1557
J01FA10
ATC
azithromycin; systemic
1.5
8.2
563
4676
JX1LA
NOMESCO Finland
Kinetic X-ray of alimentary tract with pictures
33.6
8.1
10
*
L52
ICD-10 Finland
Erythema nodosum
11.8
8.1
14
12
UJF34
NOMESCO Finland
Left colonoscopy
11.8
8.1
14
12
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
10.1
8.0
15
15
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.2
8.0
40
128
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
22.2
8.0
11
5
WX110
NOMESCO Finland
Local anesthesy
1.5
8.0
662
5695
A02BA02
ATC
ranitidine; systemic
1.9
7.9
120
675
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
6.2
7.9
20
33
L04AA01
ATC
[U] ciclosporin; systemic
8.5
7.8
16
19
JH1CG
NOMESCO Finland
Extensive MRI of perianal area
10.9
7.8
14
13
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.3
7.8
69
310
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
3.7
7.8
32
88
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.2
7.7
76
360
JFA58
NOMESCO Finland
Endoscopic dilatation of colon
18.5
7.6
11
6
TJJ00
NOMESCO Finland
Percutaneous needle biopsy of liver
18.5
7.6
11
6
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
3.4
7.6
34
101
ZX108
NOMESCO Finland
Inhalation
10.1
7.5
14
14
D11
ICPC
Diarrhoea
1.9
7.5
117
664
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
7.4
472
3824
JF1DM
NOMESCO Finland
Very extensive MRI of small bowel (more than 1.5 T)
80.7
7.4
8
*
Z92.6
ICD-10 Finland
Personal history of chemotherapy for neoplastic disease
80.7
7.4
8
*
1370
FHL
Colonoscopy, whole colon
13.5
7.4
12
9
R01AD08
ATC
fluticasone; nasal
1.6
7.3
245
1729
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.9
7.3
99
535
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
4.1
7.3
27
68
E0000UV
ATC
NA
1.5
7.3
343
2612
5551A
ICD-9 Finland
Regional enteritis, Large intestine
+∞
7.3
7
*
B73
ICPC
Leukaemia
+∞
7.3
7
*
Z01.2
ICD-10 Finland
Dental examination
1.5
7.3
403
3170
UJG02
NOMESCO Finland
Proctoscopy
5.2
7.3
21
41
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.5
7.2
322
2424
M46.9
ICD-10 Finland
Inflammatory spondylopathy, unspecified
15.9
7.2
11
7
JFF10
NOMESCO Finland
Loop enterostomy
15.9
7.2
11
7
J01MA14
ATC
moxifloxacin; systemic
2.4
7.2
60
262
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
3.0
7.2
39
133
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.5
7.2
267
1927
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.3
7.2
62
274
602
Kela drug reimbursment
Children's severe malnutrition
7.4
7.2
16
22
FM2CE
NOMESCO Finland
NA
4.9
7.2
22
46
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
30.2
7.2
9
*
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
20.2
7.1
10
5
H26.3
ICD-10 Finland
Drug-induced cataract
20.2
7.1
10
5
JAH00
NOMESCO Finland
Laparotomy
4.2
7.1
25
60
L88
ICPC
Rheumatoid/seropositive arthritis
6.6
7.1
17
26
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
6.4
7.0
17
27
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.5
6.9
51
208
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.5
6.9
54
227
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
8.3
6.8
14
17
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
6.8
6.8
16
24
K62.8
ICD-10 Finland
Other specified diseases of anus and rectum
11.0
6.8
12
11
1CX01
NOMESCO Finland
NA
40.3
6.8
8
*
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
22.7
6.7
9
*
JN4BD
NOMESCO Finland
Extensive body CT
2.2
6.6
66
314
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.1
6.6
75
377
M05BA07
ATC
risedronic acid; oral
7.9
6.6
14
18
K59.1
ICD-10 Finland
Functional diarrhoea
2.6
6.6
46
182
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.7
6.6
42
157
WX004
NOMESCO Finland
Patient-controlled sedation
8.8
6.6
13
15
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.6
6.6
200
1376
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
3.0
6.5
35
120
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.9
6.5
92
504
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.0
6.5
86
459
R19.8
ICD-10 Finland
Other specified symptoms and signs involving the digestive system and abdomen
5.7
6.5
17
30
C95.9
ICD-10 Finland
Leukaemia, unspecified
70.3
6.4
7
*
2AA01
NOMESCO Finland
NA
70.3
6.4
7
*
J45.9
ICD-10 Finland
Asthma, unspecified
1.8
6.4
111
653
A01AB04
ATC
amphotericin B; local oral
3.2
6.4
31
99
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.7
6.4
145
926
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.5
6.4
48
199
NH3EA
NOMESCO Finland
Feet X-ray examination with load
6.6
6.3
15
23
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
8.2
6.3
13
16
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.5
6.3
288
2164
4AC05
NOMESCO Finland
NA
+∞
6.3
6
*
2301
FHL
Lumbar puncture in anesthesia or operating room
+∞
6.3
6
*
JF1CM
NOMESCO Finland
Small bowel extensive MRI with with high intensity magnet
+∞
6.3
6
*
5559X
ICD-9 Finland
Regional enteritis, Unspecified site
+∞
6.3
6
*
M09.2*K51.9
ICD-10 Finland
Juvenile arthritis in ulcerative colitis
+∞
6.3
6
*
9866/3-C42.1
ICD-O-3
Acute promyelocytic leukemia, t(15;17)(q22;q11-12) of bone marrow
+∞
6.3
6
*
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
2.6
6.2
44
176
XG410
NOMESCO Finland
Flow-volume spirometry
3.4
6.2
28
85
Z01.9
ICD-10 Finland
Special examination, unspecified
2.6
6.2
41
160
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.7
6.2
40
153
L73.8
ICD-10 Finland
Other specified follicular disorders
5.8
6.2
16
28
A03FA01
ATC
metoclopramide; systemic, rectal
1.7
6.1
141
901
JL5CG
NOMESCO Finland
Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet
7.7
6.1
13
17
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.7
6.1
122
750
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
6.1
115
693
C90.0
ICD-10 Finland
Multiple myeloma
12.6
6.1
10
8
N02AA05
ATC
oxycodone; systemic
2.0
6.1
73
376
R11
ICD-10 Finland
Nausea and vomiting
2.0
6.0
71
364
UJH02
NOMESCO Finland
Anoscopy
2.7
6.0
39
148
D70.89
ICD-10 Finland
Neutropenic splenomegaly
5.2
6.0
17
33

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3018010) Neutrophils/100 leukocytes in Blood
1102
4197
16.41
314.43
22.2
4.2
%
57.7
55.2
13.20
1093
3935
(3002030) Lymphocytes/100 leukocytes in Blood
1107
4263
16.74
311.51
23.3
4.3
%
28.6
30.3
7.29
1097
3987
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
533
405
22.43
307.65
2.3
1.5
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
1160
4265
30.43
307.65
22.6
4.3
e9/l
0.0
0.0
0.13
1113
3644
(3019069) Monocytes/100 leukocytes in Blood
1104
4073
17.46
307.65
23.5
4.5
%
8.8
8.2
8.43
1094
3825
(3022145) Colonoscopy Study observation
820
736
31.33
307.65
2.4
1.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
1003
2610
16.29
307.65
19.7
4.3
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
478
147
52.50
307.65
1.9
1.5
iu/ml
1.9
0.1
0.71
94
19
(3048689) Calprotectin [Mass/mass] in Stool
1016
1154
45.51
307.65
9.9
1.4
ug/g
246.0
75.2
34.87
1000
875
(3006504) Eosinophils/100 leukocytes in Blood
1102
4040
17.37
307.65
23.1
4.3
%
2.7
2.9
3.36
1093
3752
(3001604) Monocytes [#/volume] in Blood
1160
4250
30.59
307.65
22.5
4.3
e9/l
0.5
0.5
3.08
1113
3638
(3013115) Eosinophils [#/volume] in Blood
1164
4445
30.33
307.65
23.5
4.7
e9/l
0.2
0.2
10.78
1118
3873
(3019198) Lymphocytes [#/volume] in Blood
1161
4450
28.92
307.65
22.7
4.3
e9/l
1.7
2.0
15.37
1116
3898
(3022096) Basophils/100 leukocytes in Blood
1092
3885
16.94
307.65
23.1
4.4
%
0.8
0.7
7.29
1081
3621
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1013
3428
12.00
307.65
4.2
2.1
nmol/l
73.4
73.1
0.13
996
3135
(3024561) Albumin [Mass/volume] in Serum or Plasma
1084
3040
22.36
307.65
11.9
4.2
g/l
37.0
36.8
0.51
1067
2843
(3002179) Metamyelocytes/100 leukocytes in Blood
386
485
11.13
304.16
7.6
3.6
%
0.3
0.6
1.04
101
96
(3017181) Myelocytes/100 leukocytes in Blood
395
527
10.56
296.81
8.1
3.7
%
0.4
0.8
2.27
124
128
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
722
1893
7.80
293.04
3.9
1.9
mg/l
2.7
2.7
0.25
664
1597
(3021440) Promyelocytes/100 leukocytes in Blood
382
506
10.49
288.10
8.2
3.7
%
0.0
0.1
1.88
122
118
(3013650) Neutrophils [#/volume] in Blood by Automated count
1163
4987
24.78
286.46
26.7
7.5
e9/l
3.6
3.9
7.67
1118
4272
(3025159) Blasts/100 leukocytes in Blood
366
479
10.45
278.02
8.5
3.8
%
0.0
1.1
0.65
104
101
(3017143) Hepatitis C virus Ab [Presence] in Serum
595
1459
6.95
252.33
1.5
1.7
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
227
7
400.43
232.62
3.3
6.0
mg/l
8.7
5.8
—
188
7
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
197
143
16.21
218.95
3.4
4.8
iu/ml
765.5
460.6
0.35
21
17
(3030905) Polymorphonuclear cells [#/volume] in Blood
168
99
19.49
207.52
5.6
2.0
e9/l
3.9
4.1
0.47
168
99
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
168
104
18.55
202.52
5.9
2.1
%
58.2
53.3
2.65
168
104
(3005719) IgG [Mass/volume] in Serum or Plasma
323
567
7.37
185.98
5.3
2.2
g/l
11.1
10.6
1.11
306
511
(3007566) Smooth muscle Ab [Titer] in Serum
209
227
10.88
179.11
1.5
1.2
titre
448.7
107.5
1.12
31
20
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
397
894
6.08
176.83
2.5
2.5
%
23.8
24.7
0.48
356
770
(3028026) IgM [Mass/volume] in Serum or Plasma
280
446
7.83
175.86
2.0
1.7
g/l
1.2
1.3
0.58
261
409
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
663
2324
5.01
174.01
1.6
1.7
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
199
233
9.99
160.81
1.4
1.2
titre
1677.5
624.0
—
8
5
(3004789) Transferrin [Mass/volume] in Serum or Plasma
394
995
5.35
152.03
2.5
2.4
g/l
2.4
2.4
0.85
375
914
(3022948) Iron [Moles/volume] in Serum or Plasma
413
1087
5.21
151.71
2.6
2.4
umol/l
14.0
14.5
0.55
393
996
(3021589) Normoblasts [#/volume] in Blood
854
3997
4.70
145.05
26.5
7.0
e9/l
0.0
0.0
0.58
778
3189
(3013707) Erythrocyte sedimentation rate by Westergren method
1095
6441
7.30
133.14
8.9
2.7
mm/h
11.9
8.9
12.71
1060
5959
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
841
4088
4.33
130.49
10.9
5.3
umol/l
10.9
11.7
0.90
814
3854
(40760892) CBC W Ordered Manual Differential panel - Blood
562
2090
4.11
127.94
15.3
3.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
168
222
8.60
122.42
1.2
1.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
376
1092
4.52
119.06
1.5
1.2
titre
666.1
420.8
1.23
92
183
(3025941) Bacteria identified in Stool by Culture
253
536
5.68
117.01
1.5
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
157
207
8.55
114.43
1.2
1.3
u/ml
228.0
209.5
0.32
104
121
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
279
657
5.20
114.25
3.5
2.3
g/l
0.2
0.2
4.51
266
609
(3001122) Ferritin [Mass/volume] in Serum or Plasma
860
4518
3.99
112.70
4.2
2.7
ug/l
115.0
94.9
0.79
834
4236
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
597
2502
3.69
110.36
5.8
2.3
u/l
53.8
56.1
1.13
571
2325
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
132
156
9.36
104.83
1.5
1.2
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
656
3073
3.43
98.80
6.9
3.0
u/l
31.8
32.4
0.19
622
2941
(40768441) Liver Pathology biopsy report
82
59
14.82
90.23
1.5
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
196
436
5.16
84.49
1.3
1.3
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
83
72
12.29
81.63
3.6
2.1
%
1.1
1.7
0.68
58
60
(3008757) Leukocyte morphology finding [Identifier] in Blood
78
63
13.15
80.16
5.2
3.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
492
2150
3.14
79.40
1.8
1.4
g/l
2.2
2.2
0.19
364
1312
(3014148) Varicella zoster virus Ab [Titer] in Serum
113
156
7.87
78.63
1.1
1.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
479
2115
3.07
75.14
20.7
5.9
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
77
69
11.84
74.09
1.6
1.1
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
70
0
+∞
73.69
2.3
0.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
111
162
7.43
73.47
1.1
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
597
3003
2.92
73.40
1.8
2.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
632
3376
2.79
67.77
2.4
1.9
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
82
93
9.37
66.78
1.6
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
157
354
4.94
66.04
1.7
1.7
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
277
952
3.46
65.17
5.0
2.7
umol/l
8.9
7.8
0.25
243
807
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
82
96
9.08
65.15
1.6
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
80
92
9.23
64.44
1.6
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
81
95
9.06
64.26
1.6
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
80
93
9.13
63.90
1.6
1.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
651
3613
2.70
63.45
8.0
6.1
mmol/l
1.2
1.2
0.14
541
3085
(3005988) Vibrio sp identified in Specimen by Organism specific culture
80
94
9.03
63.36
1.6
1.2
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
603
3236
2.69
62.69
7.5
5.5
mmol/l
1.2
1.2
0.18
554
2935
(40768797) Stomach Pathology biopsy report
281
1017
3.28
60.43
1.3
1.2
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
60
51
12.32
59.58
3.5
2.1
%
62.2
57.6
0.54
35
39
(3023368) Bacteria identified in Blood by Culture
391
1726
2.85
59.00
5.6
3.8
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
551
2894
2.64
58.91
2.1
1.7
pmol/l
97.8
97.0
0.14
364
1527
(3033658) Prothrombin time (PT) actual/Normal
442
2092
2.74
58.16
9.5
3.6
%
94.9
93.4
0.71
431
2040
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
56
47
12.43
56.01
1.2
1.1
miu/ml
1462.6
1493.4
0.05
56
47
(3019309) Folate [Moles/volume] in Red Blood Cells
282
1078
3.10
54.81
2.1
1.6
nmol/l
1087.5
1142.0
0.47
197
839
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
113
227
5.38
54.06
1.3
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
342
1465
2.85
53.99
2.6
1.5
pmol/l
22330521.7
30055506.5
0.12
309
1271
(3024980) IgG subclass 4 [Mass/volume] in Serum
81
117
7.34
53.90
2.6
1.4
g/l
0.7
0.7
0.06
59
88
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
61
63
10.13
53.11
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
61
63
10.13
53.11
1.1
1.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
92
155
6.33
52.94
1.3
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
62
67
9.69
52.23
1.1
1.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
517
2753
2.51
52.18
7.3
6.2
inr
1.1
1.1
2.01
195
867
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
150
392
4.22
52.01
1.3
1.4
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
204
668
3.46
50.98
6.2
3.0
%
1.7
1.6
0.41
189
596
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
227
797
3.27
50.68
3.9
2.3
u/l
31.1
97.8
0.59
207
691
(3036481) Cortisol [Moles/volume] in Serum or Plasma
225
787
3.27
50.54
2.5
1.8
nmol/l
338.9
379.9
2.80
214
736
(3023520) Reticulocytes [#/volume] in Blood
160
449
3.95
50.27
4.5
2.9
e9/l
68.3
70.2
0.24
124
325
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
105
211
5.35
50.16
1.4
1.4
u/ml
98.6
109.6
0.55
20
40
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1197
9843
8.61
49.03
32.0
8.9
mg/l
13.6
22.2
29.33
1111
7270
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
74
111
7.03
47.53
1.1
1.0
g/l
1.5
1.4
0.96
68
96
(3021879) Hepatitis B virus core Ab [Presence] in Serum
249
957
3.01
47.38
1.4
1.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
68
95
7.52
46.54
1.4
1.2
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
59
74
8.32
44.22
3.7
3.1
e9/l
1.1
1.3
0.62
25
45
(21494815) CD4 cells/100 lymphocytes in Specimen
58
72
8.40
43.83
3.8
2.6
%
54.9
46.7
0.90
12
12
(40761536) Microorganisms panel - Urine sediment
209
770
3.06
42.55
4.2
3.1
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
195
693
3.15
42.22
7.4
4.0
u/l
240.2
236.5
0.12
190
663
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
106
252
4.51
41.36
1.2
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
461
2560
2.28
39.89
1.4
1.3
u/ml
1.1
1.9
0.68
125
695
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
52
64
8.44
39.54
3.8
3.0
e6/l
374.0
547.1
1.65
44
59
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1103
8884
3.31
39.09
23.6
8.2
ml/min/173m2
94.7
91.9
4.46
973
7075
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
49
62
8.19
36.41
1.1
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
49
63
8.06
35.94
1.1
1.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
383
2044
2.27
35.75
4.5
3.5
ph
7.4
7.4
0.34
85
366
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
51
70
7.56
35.38
3.1
2.5
e6/l
579.8
848.3
1.62
27
27
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
33
26
13.01
34.13
1.1
1.3
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
46
60
7.93
33.32
1.3
1.1
u/l
58.1
70.2
0.35
27
42
(3021960) Folate [Moles/volume] in Serum or Plasma
310
1560
2.32
32.90
1.6
1.4
nmol/l
19.1
20.0
0.53
283
1348
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
34
32
10.90
31.43
1.1
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
76
173
4.62
31.21
1.1
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
155
578
2.92
30.42
3.3
2.3
e9/l
4.0
4.0
0.03
102
495
(3037467) Urinalysis macro (dipstick) panel - Urine
832
6190
2.06
30.13
4.7
3.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
73
167
4.58
29.79
1.1
1.1
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
94
261
3.82
29.65
15.8
5.8
mg/l
1.1
1.3
2.67
88
244
(3010503) CD19 cells [#/volume] in Blood
35
39
9.21
28.69
1.7
3.3
e9/l
0.1
0.2
0.89
35
39
(3019225) pH of Specimen
165
656
2.75
28.66
3.6
3.7
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
60
121
5.16
28.41
3.8
2.9
u/ml
1940.8
195.8
—
5
6
(21494434) Karyotype in Bone marrow
39
52
7.71
27.70
1.3
1.3
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
61
128
4.96
27.60
2.8
2.9
u/ml
13.2
40.2
0.37
61
111
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
32
6
54.68
27.28
1.2
1.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
56
111
5.24
27.03
2.4
1.8
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
393
2324
2.01
26.74
3.9
3.0
estimate
0.0
0.0
1.28
214
789
(3003458) Phosphate [Moles/volume] in Serum or Plasma
207
949
2.42
26.69
8.2
6.1
mmol/l
1.1
1.1
0.16
193
900
(3013826) Glucose [Moles/volume] in Serum or Plasma
680
4842
1.90
26.44
6.2
4.2
mmol/l
6.2
6.5
2.80
644
4425
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
40
60
6.86
25.61
4.5
2.6
%
6.8
13.5
3.74
25
36
(1175426) CD3 cells/100 lymphocytes in Blood
40
60
6.86
25.61
4.6
2.7
%
77.2
71.7
1.47
40
60
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
23
16
14.63
25.40
1.5
1.4
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
83
237
3.68
25.11
1.6
1.8
g/l
1.4
1.4
0.23
75
209
(3052851) Hemolysis interference index of Serum or Plasma
78
214
3.82
25.00
2.6
2.9
—
—
—
0
0
(4035726)
145
588
2.66
24.09
1.4
1.4
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
142
574
2.67
23.73
10.5
7.8
mmol/l
6.8
7.9
1.49
131
560
(3045142) Bone marrow Pathology biopsy report
39
62
6.46
23.64
1.4
1.5
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
26
25
10.60
23.62
1.6
1.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
347
2040
1.98
23.52
3.6
2.0
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
106
369
3.05
23.37
2.0
3.5
g/l
66.3
67.7
0.70
97
343
(3024932) HLA-DR beta [Type]
29
33
8.98
23.36
1.1
1.1
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
44
80
5.67
23.32
1.1
1.1
mg/l
276.2
282.9
0.19
39
70
(3024471) HLA-A [Type]
29
34
8.71
22.83
1.0
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
27
29
9.50
22.70
1.6
3.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
75
217
3.62
22.25
4.1
3.3
u/ml
102.7
1215.8
0.90
65
186
(3023103) Potassium [Moles/volume] in Serum or Plasma
1108
9608
2.52
21.92
20.9
10.3
mmol/l
3.9
3.9
11.08
1079
9303
(3019550) Sodium [Moles/volume] in Serum or Plasma
1105
9574
2.50
21.83
20.4
10.3
mmol/l
139.5
139.6
0.78
1077
9291
(3044640) Blood type and Crossmatch panel - Blood
423
2711
1.85
21.74
4.0
2.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
41
77
5.47
20.99
6.6
1.6
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
350
2160
1.87
19.98
3.2
2.7
e6/l
0.2
0.3
0.70
272
1556
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
45
96
4.83
19.97
2.6
1.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
25
29
8.78
19.82
1.3
1.0
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
25
29
8.78
19.82
1.3
1.0
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
347
2141
1.86
19.80
3.1
2.7
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
275
1576
1.96
19.62
2.7
2.3
e6/l
6.4
7.6
0.56
248
1364
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
35
61
5.88
19.38
2.3
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
81
270
3.14
19.21
1.2
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
81
270
3.14
19.21
1.2
1.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
374
2389
1.81
18.93
3.2
2.8
e6/l
127.3
71.4
0.22
299
1769
(42529406) Shigella sp [Presence] in Stool by Culture
81
274
3.09
18.74
1.2
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
101
391
2.72
18.29
1.1
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
127
550
2.46
18.29
3.7
4.4
ug/l
2.8
31.9
1.20
99
444
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
244
1372
1.97
18.28
1.2
1.2
u/ml
1.9
4.4
1.81
80
586
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
31
51
6.21
18.17
5.6
2.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
57
157
3.76
18.17
2.4
1.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
206
1093
2.06
18.14
2.1
1.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
35
65
5.51
18.14
2.5
1.6
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
212
1137
2.04
18.13
6.6
3.4
mmol/l
0.8
0.8
0.41
200
1088
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
39
81
4.94
17.87
1.1
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
37
74
5.12
17.69
1.2
1.2
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
745
5835
1.70
17.66
4.4
3.6
e6/l
18.5
592.5
—
6
69
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
20
20
10.15
17.62
1.2
1.6
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
28
43
6.64
17.52
1.5
1.4
u/l
7.9
1.5
1.82
12
16
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
22
26
8.60
17.17
1.3
1.0
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
22
26
8.60
17.17
1.3
1.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
598
4464
1.66
16.66
4.5
3.9
estimate
0.0
0.0
0.50
219
815
(3004588) Protein electrophoresis panel - Serum or Plasma
80
288
2.90
16.59
1.5
2.9
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
25
37
6.88
16.18
6.3
2.7
%
33.6
25.9
1.53
25
37
(3018095) Leukocytes [#/volume] in Urine
424
2915
1.69
16.05
3.6
3.2
e6/l
21.9
80.1
2.99
323
1916
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
38
85
4.58
15.95
2.5
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
54
157
3.55
15.92
2.7
1.5
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
32
62
5.27
15.85
2.3
1.2
g/l
9.5
6.6
0.74
17
44
(3024139) IgG subclass 3 [Mass/volume] in Serum
32
62
5.27
15.85
2.3
1.2
g/l
0.5
0.4
0.68
17
43
(3028192) IgG subclass 2 [Mass/volume] in Serum
32
62
5.27
15.85
2.3
1.2
g/l
2.4
2.7
0.38
17
44
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
247
1459
1.87
15.74
1.2
1.2
iu/ml
15.7
17.0
0.13
53
409
(3000060) B lymphocytes [#/volume] in Blood
22
29
7.71
15.73
7.0
2.6
e6/l
187.1
321.9
0.63
14
21
(3004616) Nuclear Ab [Presence] in Serum
35
74
4.84
15.71
1.3
1.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
597
4500
1.63
15.66
3.7
2.8
estimate
0.0
0.0
0.80
214
768
(3035350) Ketones [Presence] in Urine by Test strip
591
4444
1.63
15.66
3.6
2.8
estimate
0.0
0.0
0.50
213
786
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
564
4220
1.62
15.05
6.2
3.8
—
—
—
0
0
(4062490)
32
65
5.03
15.05
2.3
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
37
86
4.40
14.82
8.2
1.9
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
483
3503
1.62
14.48
3.8
2.8
—
—
—
0
0
(3026782) Osmolality of Urine
249
1510
1.81
14.47
2.8
2.4
mosm/kgh2o
555.2
567.1
0.31
226
1285
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
388
2673
1.66
14.23
2.6
2.7
ng/l
35.7
41.2
0.11
209
1439
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
79
307
2.68
14.20
1.6
1.7
u/l
42.5
41.8
0.12
70
277
(3018677) aPTT in Platelet poor plasma by Coagulation assay
198
1127
1.90
14.04
6.8
2.1
s
30.7
29.6
1.47
192
1094
(3041096) Erythrocytes [Presence] in Urine by Automated
378
2614
1.64
13.53
3.6
2.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
49
151
3.34
13.24
3.3
2.7
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
33
77
4.38
13.17
2.1
1.4
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
56
188
3.07
13.15
9.0
1.4
mmol/l
3.5
3.6
0.11
56
177
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
18
24
7.60
12.72
3.9
3.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
18
24
7.60
12.72
3.9
3.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
53
178
3.07
12.45
10.8
1.7
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
295
1950
1.67
12.43
3.9
1.8
mg/l
1.2
1.0
0.52
221
1403
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
110
528
2.19
12.43
3.3
3.3
mmol/l
1.2
1.2
0.96
98
442
(40761511) CBC panel - Blood by Automated count
1151
10598
2.31
12.38
21.3
8.8
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
293
1940
1.67
12.25
5.0
2.2
umol/l
1957.5
6212.2
2.09
266
1741
(3000570) Elastase.pancreatic [Mass/mass] in Stool
59
213
2.86
12.21
1.7
1.4
ug/g
252.8
307.4
0.99
33
113
(3023410) Appearance of Cerebral spinal fluid
35
91
3.93
12.14
14.5
2.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
60
220
2.82
12.07
2.6
1.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
71
286
2.57
11.90
1.3
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
49
162
3.11
11.83
7.5
3.8
u/ml
0.4
0.3
0.24
30
83
(36660697) Celiac disease serology panel - Serum
159
890
1.90
11.78
1.2
1.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
124
640
2.04
11.60
11.9
7.8
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
52
182
2.94
11.39
1.2
1.2
u/ml
94.7
2.8
—
6
18
(3036489) Thrombin time
81
355
2.37
11.34
9.4
2.4
s
22.2
21.1
1.46
75
324
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
53
190
2.87
11.12
1.6
2.0
ug/l
1.4
1.1
0.14
46
171
(3009343) pH of Capillary blood
100
484
2.16
11.07
3.5
4.7
ph
7.4
7.4
0.24
13
50
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
52
185
2.89
11.07
1.2
1.2
u/ml
13.1
13.7
—
8
30
(40765096) Chromosome analysis panel by Banding
15
19
7.98
11.02
1.3
1.2
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
54
198
2.81
10.88
10.6
1.6
e6/l
183.5
20.2
0.43
49
159
(3015377) Calcium [Moles/volume] in Serum or Plasma
353
2509
1.57
10.86
2.9
3.1
mmol/l
2.3
2.4
2.18
309
2265
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
100
488
2.14
10.84
3.5
4.7
kpa
5.0
5.2
0.96
91
460
(3022217) INR in Platelet poor plasma by Coagulation assay
132
715
1.95
10.76
13.3
15.5
inr
1.0
1.2
2.08
33
122
(3002032) Base excess in Venous blood by calculation
130
702
1.95
10.70
11.5
4.1
mmol/l
1.8
1.6
0.25
103
558
(3020393) Adenovirus Ag [Presence] in Stool
14
17
8.32
10.63
2.1
2.2
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
27
64
4.29
10.59
1.5
1.5
umol/l
10.5
10.8
0.13
27
59
(3021447) Carbon dioxide [Partial pressure] in Venous blood
130
706
1.94
10.52
11.5
4.1
kpa
5.8
5.8
0.37
123
686
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
24
52
4.69
10.50
1.5
2.6
%
39.8
43.4
—
6
17
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
90
428
2.19
10.41
15.1
4.5
mmol/l
24.4
23.8
1.39
85
397
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
27
65
4.22
10.39
2.3
1.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
827
7074
1.51
10.27
4.8
2.8
u/l
50.8
40.8
2.79
802
6742
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
228
1479
1.66
10.13
2.5
2.6
ng/l
770.3
1066.0
0.83
183
1191
(3032057) Clostridioides difficile [Presence] in Stool
15
9
16.86
9.88
1.9
2.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
15
9
16.86
9.88
1.3
1.2
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
16
25
6.47
9.82
1.6
2.5
%
10.3
8.3
0.30
16
25
(21494814) CD8 cells/100 lymphocytes in Specimen
16
25
6.47
9.82
1.6
2.4
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
14
19
7.44
9.71
1.6
1.9
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
172
1045
1.75
9.70
2.1
1.8
—
—
—
0
0
(3002256) Pathology report gross observation
174
1062
1.74
9.65
1.3
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
42
145
2.96
9.46
2.5
2.5
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1206
11496
3.32
9.41
46.1
13.7
e9/l
276.7
255.5
20.08
1201
11197
(40767503) Oxygen content in Capillary blood by calculation
38
125
3.10
9.30
1.9
2.0
%
18.1
16.9
0.88
18
64
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
67
297
2.33
9.18
2.0
1.7
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
39
132
3.02
9.10
1.2
1.2
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
1206
11513
3.25
9.04
46.0
13.7
e12/l
4.4
4.6
33.97
1201
11201
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
13
18
7.29
8.85
1.2
1.3
ug/l
9.2
8.4
0.23
13
18
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
92
472
2.03
8.75
3.7
4.7
mmol/l
0.9
1.4
0.81
65
346
(44816559) Phosphatidylethanol [Mass/volume] in Blood
61
266
2.36
8.68
1.2
1.3
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
40
142
2.88
8.60
1.5
2.8
g/l
0.0
1.0
2.28
33
129
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
62
275
2.32
8.50
1.6
1.7
—
—
—
0
0
(44806118)
30
91
3.35
8.38
2.8
1.5
—
—
—
0
0
(44790049)
30
91
3.35
8.38
2.8
1.5
—
—
—
0
0
(44790048)
30
91
3.35
8.38
2.8
1.5
—
—
—
0
0
(44790047)
30
91
3.35
8.38
2.8
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
128
744
1.80
8.37
3.1
2.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
29
87
3.39
8.24
1.2
1.9
—
—
—
0
0
(3022313) Gas panel - Capillary blood
75
367
2.11
8.11
3.5
4.9
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
145
2.74
7.72
1.3
2.6
g/l
11.6
10.8
0.28
34
129
(3011436) Histone Ab [Units/volume] in Serum
12
8
15.13
7.72
1.2
1.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
151
2.70
7.70
1.3
2.6
g/l
3.3
3.0
0.86
34
124
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
105
597
1.83
7.38
2.8
2.2
ml/min/173m2
76.6
78.0
0.13
49
210
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
15
30
5.05
7.19
2.1
1.3
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
15
30
5.05
7.19
2.1
1.3
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
15
30
5.05
7.19
2.1
1.3
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
15
30
5.05
7.19
2.1
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
122
733
1.74
7.13
2.2
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
32
112
2.91
7.09
1.4
1.4
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
13
23
5.70
7.07
1.2
1.5
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
158
2.58
7.07
1.3
2.6
g/l
3.8
3.7
0.05
33
121
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
158
2.58
7.07
1.3
2.6
g/l
7.2
7.2
0.07
35
127
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
158
2.58
7.07
1.3
2.6
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
35
129
2.76
7.07
1.7
4.2
mg/l
30.2
28.0
0.15
27
108
(3026008) Bacteria identified in Urine by Culture
296
2195
1.46
7.00
2.7
2.4
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
59
279
2.17
6.99
1.4
1.2
u/ml
0.2
0.7
—
7
18
(3000494) Fungus identified in Specimen by Culture
151
966
1.64
6.98
1.5
1.3
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
14
27
5.23
6.98
1.1
1.5
iu/ml
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
11
8
13.86
6.89
3.0
1.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
22
62
3.59
6.88
4.1
3.0
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
34
126
2.75
6.80
1.7
4.2
ratio
1.1
2.2
—
5
16
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
17
40
4.30
6.76
1.1
1.2
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
10
6
16.79
6.75
5.1
2.8
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
83
454
1.89
6.61
2.1
1.5
u/l
8.1
7.7
0.11
56
368
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
17
41
4.19
6.56
1.2
1.1
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
34
129
2.68
6.52
1.7
4.2
mg/l
33.1
45.0
1.06
27
109
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
12
22
5.50
6.29
1.6
2.6
ug/l
58.2
110.7
0.84
12
22
(40760888) Immunoglobulin light chains.free panel - Serum
27
92
2.98
6.29
1.8
4.5
—
—
—
0
0
(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
6
0
+∞
6.25
4.0
0.0
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
103
613
1.74
6.23
2.0
1.4
iu/l
20.0
20.2
0.03
82
508
(3004716) Salmonella sp identified in Stool by Organism specific culture
110
671
1.70
6.10
1.2
1.3
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
16
39
4.14
6.10
1.1
1.1
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
10
8
12.59
6.08
1.5
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
187
1302
1.51
5.99
2.8
2.5
e6/l
0.8
0.9
0.23
107
685
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
62
319
1.99
5.92
1.2
1.1
u/ml
23.4
5.1
—
6
57
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
111
685
1.68
5.90
1.0
1.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
119
748
1.65
5.90
2.2
1.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
181
1258
1.51
5.84
2.8
2.6
e6/l
2.9
2.8
0.01
102
651
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
24
80
3.04
5.82
1.4
1.3
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
20
60
3.37
5.73
1.0
1.7
iu/ml
—
1316081.3
—
0
8
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
20
61
3.32
5.59
4.6
2.3
pg
32.7
32.4
0.07
20
61
(3051611) Lipemic interference index of Serum or Plasma
20
61
3.32
5.59
3.4
3.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
145
970
1.56
5.57
1.6
1.5
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
11
21
5.28
5.53
2.4
1.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
11
21
5.28
5.53
2.5
1.4
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
11
21
5.28
5.53
2.4
1.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
18
53
3.43
5.32
1.1
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
15
39
3.88
5.27
1.1
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
46
890
0.50
5.27
1.3
1.4
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
18
54
3.37
5.17
1.5
1.8
umol/l
28.5
27.2
0.05
18
54
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
28
109
2.61
5.16
1.2
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
31
127
2.48
5.15
1.5
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
31
127
2.48
5.15
1.5
1.2
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
8
6
13.41
5.08
1.4
1.0
—
—
—
0
0
(4034850)
52
268
1.98
4.99
10.3
6.5
—
—
—
0
0
(3013512) EKG study
261
2002
1.39
4.94
3.2
2.9
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
16
46
3.51
4.90
1.4
2.0
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
22
78
2.85
4.83
1.6
1.4
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
36
163
2.24
4.82
2.3
3.1
mmol/l
24.1
24.8
0.49
31
149
(3034274) Bile acid [Moles/volume] in Serum --fasting
46
230
2.04
4.80
3.3
2.4
umol/l
11.5
5.2
0.79
36
179
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
11
24
4.62
4.78
1.7
1.5
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
35
158
2.25
4.72
1.4
1.2
u/ml
2.6
3.7
0.27
17
51
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
14
38
3.72
4.65
1.1
1.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
33
147
2.28
4.60
2.3
3.0
mmol/l
2.1
2.1
0.03
17
89
(3041672) Baker's yeast Ab [Presence] in Serum
7
5
14.07
4.58
1.0
1.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
273
2139
1.35
4.49
2.2
1.9
u/l
121.3
273.1
2.08
258
2032
(3021901) Oxygen saturation in Capillary blood
26
105
2.51
4.48
2.3
2.5
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
16
49
3.30
4.47
3.7
3.5
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
17
55
3.12
4.37
1.1
1.1
—
—
—
0
0
(3010421) pH of Blood
36
171
2.14
4.32
2.2
3.0
ph
7.4
7.4
0.12
31
144
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
965
8984
1.34
4.31
4.5
4.3
mu/l
1.7
2.1
1.32
899
8402
(3024354) Oxygen [Partial pressure] in Venous blood
94
606
1.60
4.26
14.7
3.6
kpa
4.8
4.8
0.01
87
587
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
84
1294
0.62
4.26
1.3
1.6
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
51
277
1.88
4.24
2.1
3.5
g/l
0.3
0.2
0.32
18
128
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
24
96
2.53
4.23
1.1
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
13
36
3.64
4.21
1.0
1.0
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
9
13
6.96
4.16
2.3
1.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
36
175
2.09
4.09
1.1
1.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
8
10
8.04
4.06
4.0
2.0
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
31
143
2.20
4.01
2.2
2.2
g/l
139.4
133.1
0.73
22
114
(3026389) Candida sp identified in Specimen by Organism specific culture
27
118
2.32
3.96
1.3
1.3
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
38
191
2.02
3.96
2.9
2.4
ug/l
157.7
511.7
0.89
30
185
(3024891) Influenza virus A+B Ag [Presence] in Specimen
52
291
1.82
3.96
1.4
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
13
38
3.45
3.91
2.0
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
10
24
4.19
3.89
1.8
1.5
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
8
11
7.31
3.86
1.0
1.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
25
108
2.34
3.77
2.0
1.3
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
6
5
12.05
3.76
1.0
1.0
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
74
465
1.63
3.75
3.3
4.7
ng/l
65.5
80.4
1.77
65
427
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
16
55
2.93
3.74
2.3
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
16
55
2.93
3.74
2.3
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
16
55
2.93
3.74
2.3
1.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
19
72
2.66
3.74
1.3
1.5
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
8
12
6.70
3.67
1.3
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
8
12
6.70
3.67
1.0
1.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
83
540
1.58
3.65
3.0
2.6
—
—
—
0
0
(4306422)
32
156
2.08
3.63
1.1
1.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
32
156
2.08
3.63
1.3
1.2
u/ml
2.9
4.0
0.55
12
70
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
15
51
2.97
3.58
1.2
1.1
ratio
1.0
1.0
—
8
19
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
18
68
2.67
3.57
1.2
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
32
158
2.05
3.52
2.1
2.6
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
8
13
6.19
3.50
2.3
3.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
31
3.57
3.48
1.8
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
332
2761
1.28
3.47
1.8
1.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
69
435
1.62
3.47
1.6
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
218
1715
1.33
3.45
1.6
1.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
374
3161
1.26
3.41
1.8
1.6
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
39
210
1.89
3.38
1.8
1.5
nmol/l
0.4
0.4
0.03
33
175
(3005322) IgE [Units/volume] in Serum or Plasma
91
616
1.52
3.37
1.3
1.2
u/ml
67.2
233.2
3.52
83
568
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
127
919
1.43
3.36
3.6
3.5
%
31.8
31.3
0.19
98
649
(3042733) HLA Ab [Presence] in Serum
10
27
3.73
3.36
2.3
4.4
—
—
—
0
0
(3000012) Reticulocyte production index
10
27
3.73
3.36
1.9
1.7
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
8
14
5.74
3.34
1.1
1.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
176
1347
1.36
3.34
2.9
3.0
ng/l
343.1
674.1
0.65
102
850
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
62
388
1.63
3.23
1.3
1.5
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
12
38
3.18
3.22
1.1
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
22
98
2.27
3.14
1.6
1.3
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
10
29
3.47
3.05
2.8
5.0
mg/l
125.2
68.0
—
10
21
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
35
189
1.88
3.03
1.7
1.5
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
20
87
2.32
3.01
1.2
1.7
mmol/l
78.4
65.3
0.53
15
78
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
18
75
2.42
2.97
1.4
1.7
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
32
169
1.92
2.97
1.2
1.1
u/ml
7.4
22.4
—
5
11
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
818
7594
1.23
2.94
3.9
3.7
pmol/l
14.9
14.5
6.01
754
7002
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
890
8346
1.24
2.86
3.7
3.5
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
17
71
2.41
2.81
1.4
1.3
—
73.7
—
0
7
(3011648) Oxygen content in Venous blood
15
59
2.56
2.79
16.6
4.0
%
10.9
11.4
0.17
15
59
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
21
97
2.19
2.78
1.5
1.3
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
15
60
2.52
2.70
1.2
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
235
1929
1.27
2.69
3.1
2.8
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
52
328
1.61
2.67
8.2
9.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
15
61
2.48
2.62
3.1
2.4
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
0
70
0.00
2.59
0.0
2.2
—
149.3
—
0
63
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
63
419
1.53
2.59
3.1
2.7
ng/l
94.1
144.8
1.27
55
366
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
29
512
0.56
2.57
1.4
1.5
mg/l
3.9
3.3
0.19
22
347
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
9
25
3.62
2.57
2.0
2.3
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
9
25
3.62
2.57
1.3
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
34
193
1.78
2.56
1.1
1.1
u/ml
2.2
2.6
0.19
14
103
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
12
44
2.74
2.55
1.2
1.2
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
9
26
3.48
2.48
1.4
1.2
—
70.0
—
0
5
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
102
754
1.38
2.44
2.3
2.4
u/l
11484.2
4068.6
0.64
28
304
(3045424) Erythrocytes [Presence] in Urine
28
152
1.86
2.44
1.4
1.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
28
152
1.86
2.44
9.4
3.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
27
145
1.88
2.43
1.1
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
10
34
2.96
2.41
2.4
2.6
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
6
12
5.02
2.40
1.2
1.1
mmol/l
1.5
3.0
—
6
12
(3028679) Herpes simplex virus Ab [Presence] in Serum
15
64
2.36
2.39
1.0
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
17
77
2.22
2.38
1.1
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
93
683
1.39
2.32
6.9
7.5
mmol/l
0.2
0.8
0.81
75
537
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
24
126
1.92
2.31
1.9
2.9
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
21
105
2.02
2.31
1.1
1.1
—
—
—
0
0
(4268621)
21
105
2.02
2.31
2.6
2.3
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
12
47
2.57
2.27
1.2
3.1
umol/l
41.3
138.1
—
6
29
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
5
9
5.57
2.21
1.6
1.3
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
20
100
2.02
2.21
1.5
1.4
nmol/l
0.5
0.6
0.13
20
95
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
6
14
4.30
2.15
1.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
6
14
4.30
2.15
1.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
6
14
4.30
2.15
1.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
6
14
4.30
2.15
1.0
1.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
8
25
3.21
2.09
3.5
3.3
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
16
75
2.15
2.09
1.4
2.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
22
117
1.90
2.07
1.5
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
22
391
0.55
2.05
4.0
3.7
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
56
384
1.48
2.05
1.6
1.5
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
15
69
2.19
2.05
1.0
1.1
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
6
15
4.01
2.04
1.2
1.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
6
15
4.01
2.04
1.5
1.1
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
16
76
2.12
2.03
2.1
2.8
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
8
26
3.09
2.01
1.6
2.6
u/ml
1187.4
540.1
—
8
26
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
32
2.83
2.00
1.7
1.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
13
57
2.29
1.98
1.4
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
357
4015
0.84
1.97
2.3
2.4
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
21
3.35
1.96
3.3
5.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
70
506
1.41
1.95
1.3
1.3
miu/ml
219.1
225.8
0.04
23
252
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
10
39
2.58
1.92
1.0
1.1
iu/ml
191.7
200.4
—
10
39
(3010937) Rubella virus Ab [Presence] in Serum
5
12
4.18
1.82
1.0
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
32
199
1.62
1.81
2.1
2.3
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
8
29
2.77
1.79
1.1
1.3
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
6
18
3.34
1.75
1.0
1.0
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
6
18
3.34
1.75
1.0
1.0
%
96.5
94.1
—
6
18
(3034426) Prothrombin time (PT)
8
30
2.68
1.72
1.3
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
48
2.30
1.70
1.5
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
11
48
2.30
1.70
1.1
1.1
—
—
—
0
0
(4010399)
64
470
1.38
1.66
1.3
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
17
90
1.90
1.65
1.2
1.4
nmol/l
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
17
90
1.90
1.65
1.6
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
7
25
2.81
1.65
12.1
2.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
37
544
0.67
1.62
1.5
2.0
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
5
14
3.58
1.61
1.2
1.6
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
10
43
2.34
1.60
1.1
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
44
623
0.70
1.59
1.5
3.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
20
114
1.77
1.57
2.2
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
17
92
1.86
1.56
1.1
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
50
688
0.72
1.54
2.0
2.8
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
42
0.00
1.52
0.0
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
5
15
3.34
1.52
2.0
4.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1023
9911
1.19
1.51
30.1
10.2
%
40.2
40.8
2.56
795
8100
(3003888) Timothy IgE Ab [Units/volume] in Serum
17
294
0.57
1.50
1.1
1.1
u/ml
6.7
6.0
—
5
167
(4146454)
12
58
2.08
1.49
2.3
2.8
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
37
251
1.49
1.49
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
37
251
1.49
1.49
1.1
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
14
73
1.93
1.44
1.4
1.9
—
—
—
0
0
(3019060) Gas panel - Arterial blood
49
354
1.40
1.43
4.8
5.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
63
822
0.75
1.39
2.3
2.7
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
12
60
2.01
1.38
3.0
3.6
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
16
89
1.81
1.37
1.9
1.4
pmol/l
342.1
448.3
0.32
16
67
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
6
23
2.62
1.37
1.0
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
69
886
0.77
1.36
2.2
2.6
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
5
17
2.95
1.36
1.0
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
70
896
0.77
1.35
2.2
2.6
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
47
2.14
1.34
1.5
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
21
128
1.65
1.33
1.1
1.0
titre
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
70
892
0.77
1.31
2.2
2.3
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
6
24
2.51
1.30
1.2
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
6
24
2.51
1.30
1.2
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
6
24
2.51
1.30
1.2
1.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
9
43
2.10
1.30
1.1
2.8
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
8
34
2.36
1.29
1.5
1.7
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
223
1962
1.17
1.28
3.3
3.3
mg/l
346.5
235.3
0.15
158
1302
(3011985) Renin [Units/volume] in Plasma
16
92
1.75
1.25
2.1
1.3
mu/l
55.3
143.1
0.38
16
78
(3043410) Blood group antigens tested for on Red Blood Cells
6
25
2.41
1.24
1.3
1.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
19
2.64
1.21
1.8
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
70
880
0.78
1.20
2.2
2.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
142
1655
0.84
1.18
3.4
3.4
%
22.3
21.4
0.27
65
582
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
216
1911
1.16
1.16
1.6
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
43
317
1.37
1.16
2.3
2.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
20
2.51
1.15
1.4
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
5
20
2.51
1.15
1.0
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
49
374
1.32
1.07
1.4
1.7
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
40
297
1.36
1.05
1.3
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
28
394
0.70
1.05
1.6
1.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
13
216
0.60
1.05
1.5
1.5
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
22
2.28
1.03
1.4
1.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
79
647
1.24
1.01
3.2
3.3
pmol/l
4.6
4.7
0.34
71
588
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
103
1213
0.84
0.99
2.8
2.5
ug/l
0.7
0.7
0.29
63
639
(3011897) Casein IgE Ab [Units/volume] in Serum
0
30
0.00
0.97
0.0
1.5
—
5.1
—
0
6
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
13
77
1.70
0.95
1.6
1.3
—
—
—
0
0
(3020891) Body temperature
34
251
1.36
0.94
4.9
4.5
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
6
27
2.23
0.93
1.0
1.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
33
243
1.37
0.93
1.5
1.9
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
39
507
0.76
0.91
1.7
1.6
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
16
243
0.65
0.91
1.4
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
252
2294
1.12
0.90
1.8
1.6
mmol/l
1.3
1.4
2.02
229
1992
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
138
1206
1.16
0.90
3.5
2.7
mmol/l
2.4
2.4
0.75
118
1058
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
857
8302
1.11
0.89
4.5
4.4
mmol/mol
37.5
38.2
1.74
804
7843
(3045683) HLA typing for celiac disease panel - Blood or Tissue
13
79
1.65
0.88
1.0
1.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
51
405
1.27
0.87
1.6
1.3
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
8
45
1.78
0.84
2.9
3.2
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
20
138
1.46
0.82
1.7
2.8
nmol/l
24.9
20.9
0.57
20
133
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
15
97
1.55
0.81
1.0
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
56
683
0.81
0.80
1.4
1.4
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
10
58
1.73
0.79
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
10
58
1.73
0.79
1.2
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
6
33
1.82
0.79
1.2
1.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
25
0.00
0.79
0.0
1.6
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
13
199
0.65
0.78
1.3
1.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
40
313
1.29
0.78
1.5
1.3
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
0
26
0.00
0.78
0.0
3.1
—
30.3
—
0
20
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
13
82
1.59
0.78
1.0
1.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
138
1552
0.88
0.77
1.2
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
217
1980
1.12
0.76
3.5
3.0
kg/l
1.0
1.0
0.14
25
284
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
28
0.00
0.76
0.0
1.0
—
30.5
—
0
28
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
10
59
1.70
0.76
1.2
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
10
59
1.70
0.76
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
10
59
1.70
0.76
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
10
59
1.70
0.76
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
10
59
1.70
0.76
1.2
1.1
—
—
—
0
0
(4027681)
11
67
1.65
0.75
1.1
1.3
—
—
—
0
0
(3044889) 12 lead EKG panel
618
5932
1.08
0.73
3.0
2.9
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
25
186
1.35
0.70
5.0
4.5
mmol/l
3.8
3.8
0.00
25
171
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
7
117
0.60
0.68
1.3
1.7
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
270
2509
1.10
0.67
3.1
3.4
mmol/l
8.1
8.4
0.41
241
2165
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
26
197
1.33
0.66
1.3
1.1
—
10.4
—
0
21
(3000330) Specific gravity of Urine by Test strip
27
349
0.77
0.65
2.6
2.6
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
24
181
1.33
0.63
1.8
1.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
109
1226
0.88
0.63
2.0
1.9
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
8
49
1.64
0.62
1.4
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
38
467
0.81
0.62
2.3
1.7
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
30
1.67
0.61
1.0
1.1
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
21
0.00
0.60
0.0
1.2
—
328.9
—
0
15
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.1
—
1.3
—
0
16
(3020682) Albumin/Creatinine [Ratio] in Urine
223
2067
1.10
0.60
4.3
4.1
mg/mmol
13.2
10.6
0.20
156
1353
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
102
1144
0.88
0.58
1.7
1.9
—
—
—
0
0
(3039000) Anion gap in Blood
18
132
1.37
0.57
5.3
6.4
mmol/l
10.9
11.6
0.34
18
117
(44813793)
10
65
1.54
0.55
1.0
1.0
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
18
133
1.36
0.55
5.3
6.4
mmol/l
103.3
105.6
0.91
18
118
(3000492) Spirometry study
106
949
1.13
0.55
1.2
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
129
1417
0.90
0.52
2.1
2.1
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
6
99
0.60
0.52
1.0
1.1
—
5.9
—
0
17
(40768800) Prostate Pathology biopsy report
6
100
0.60
0.51
1.3
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
38
456
0.83
0.51
1.6
1.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
896
9130
0.93
0.51
3.5
3.3
mmol/l
1.3
1.3
1.27
856
8603
(3044941) Cell count panel - Synovial fluid
11
75
1.47
0.50
1.3
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
935
9505
0.93
0.48
3.6
3.6
mmol/l
1.4
1.4
0.84
891
8968
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
7
47
1.49
0.47
1.0
1.1
—
1.8
—
0
5
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
14
102
1.38
0.47
1.0
1.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
45
383
1.18
0.47
1.6
1.7
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
97
874
1.12
0.47
2.5
2.1
nmol/l
11.8
13.0
0.90
81
789
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
13
174
0.74
0.43
3.9
2.5
ug/min
35.0
83.8
—
8
109
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
31
1.62
0.43
1.2
1.0
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
38
444
0.85
0.41
1.5
1.4
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
8.9
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(4198724)
7
101
0.69
0.39
8.9
4.0
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
5
35
1.43
0.39
1.0
1.1
—
11.9
—
0
6
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
19
0.00
0.39
0.0
5.6
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
38
441
0.86
0.38
1.5
1.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
172
1613
1.08
0.38
1.6
1.9
%
1.4
1.4
0.30
148
1475
(40765089) Chromosome analysis panel - Blood by G-banded
9
68
1.33
0.37
1.0
1.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
97
1055
0.91
0.36
1.5
1.5
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
12
90
1.34
0.36
1.3
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
13
168
0.77
0.35
3.7
3.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
79
0.63
0.35
1.4
1.7
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
54
605
0.89
0.34
1.5
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
951
9628
0.95
0.34
3.8
3.9
mmol/l
2.8
2.9
3.09
896
9066
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
45
1.33
0.33
2.3
3.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
16
199
0.80
0.33
1.2
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
28
238
1.18
0.32
1.5
1.5
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
10
74
1.35
0.32
1.3
1.3
nmol/l
1.0
1.3
—
10
65
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
45
507
0.88
0.32
2.1
2.1
ug/l
8.0
7.3
0.04
38
463
(3047007) Chlamydophila sp Ab [Presence] in Serum
20
165
1.22
0.31
1.2
1.2
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
7
52
1.35
0.31
1.7
3.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
49
545
0.89
0.29
1.5
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
185
1943
0.94
0.29
1.7
1.8
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
7
57
1.23
0.29
4.6
8.2
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
49
544
0.90
0.28
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
49
544
0.90
0.28
1.5
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
49
542
0.90
0.27
1.5
1.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
8
66
1.21
0.26
1.0
1.1
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
27
236
1.15
0.24
4.3
4.9
%
1.0
0.9
0.56
27
218
(4094501)
24
208
1.16
0.24
1.0
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
5
40
1.25
0.22
1.2
1.5
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
11
0.00
0.21
0.0
2.8
—
0.4
—
0
11
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
18.0
—
0
11
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
5
43
1.16
0.21
1.4
1.6
g/l
28.2
34.5
—
5
35
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
13
0.00
0.21
0.0
1.2
—
1.6
—
0
13
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
13
0.00
0.21
0.0
7.2
—
—
—
0
0
(4038314)
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
6
52
1.15
0.19
1.0
1.0
—
6.5
—
0
7
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
200
2066
0.96
0.18
4.0
3.7
ug/l
1.7
1.8
0.20
181
1888
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
896
9037
0.97
0.18
3.6
3.5
mmol/l
5.7
5.7
0.48
838
8412
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
10
82
1.22
0.17
2.3
1.5
g/l
0.8
1.0
—
10
82
(1617658) Protocol used for examination of sentinel lymph nodes
5
67
0.75
0.17
1.0
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
20
177
1.13
0.16
5.0
3.2
mg/l
33.2
26.9
0.22
11
112
(40761995) Spermatozoa Progressive [#/volume] in Semen
8
73
1.10
0.15
2.1
2.9
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
8
73
1.10
0.15
4.3
5.9
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
84
881
0.95
0.15
4.7
4.9
—
—
—
0
0
(4281824)
9
79
1.14
0.15
1.2
1.1
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
12
104
1.16
0.12
1.0
1.2
u/ml
0.1
2.3
—
6
39
(3014051) Protein [Presence] in Urine by Test strip
16
179
0.89
0.12
1.5
1.8
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
19
172
1.11
0.11
1.3
2.0
—
1360.0
—
0
8
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
26
240
1.09
0.11
4.3
4.9
%
1.6
1.7
0.34
26
220
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
16
177
0.90
0.10
1.3
1.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
5
48
1.04
0.09
2.2
1.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
220
2162
1.02
0.09
2.3
2.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
6
57
1.05
0.08
1.0
1.4
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
40
419
0.95
0.08
1.6
1.7
nmol/l
36.0
38.1
0.34
40
407
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
18
166
1.09
0.07
1.1
1.1
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
6
73
0.82
0.07
2.3
2.4
mmol/l
4.0
4.0
—
6
73
(3035285) Chloride [Moles/volume] in Venous blood
6
73
0.82
0.07
2.3
2.4
mmol/l
107.8
105.4
—
6
73
(3033705) Calcium.ionized [Moles/volume] in Venous blood
6
73
0.82
0.07
2.3
2.4
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
29
274
1.06
0.07
1.7
2.0
iu/l
3.2
5.0
0.96
12
106
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
57
550
1.04
0.07
2.4
1.8
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
9
84
1.07
0.07
1.2
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
38
397
0.96
0.07
1.6
1.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
951
9542
0.99
0.06
3.6
3.6
mmol/l
4.6
4.7
3.33
905
9047
(3021387) Prolactin [Units/volume] in Serum or Plasma
64
622
1.03
0.06
1.3
1.6
mu/l
293.9
289.7
0.04
56
563
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
81
829
0.98
0.05
1.2
1.2
iu/ml
77.5
152.0
2.35
33
327
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
26
248
1.05
0.05
1.1
1.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
14
131
1.07
0.03
1.5
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
55
540
1.02
0.02
3.3
2.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
237
2384
0.99
0.02
2.4
2.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
62
627
0.99
0.01
1.2
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
20
194
1.03
0.00
1.0
1.3
—
—
—
0
0
(1002224) Polysomnography panel
50
498
1.00
0.00
1.0
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
74
739
1.00
0.00
1.6
1.6
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
12
115
1.04
0.00
1.3
1.2
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
20
205
0.98
0.00
1.5
2.2
—
4.8
—
0
5
(40758358) Immune stain study
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
12.5
—
0
7
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
9
92
0.98
0.00
1.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
9
98
0.92
0.00
1.0
1.1
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
6
0.00
0.00
0.0
5.0
—
431.3
—
0
6
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002719) Hemoglobin [Mass/volume] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013762) Body weight Measured
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
6
68
0.88
0.00
1.2
1.7
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
4.4
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
7
0.00
0.00
0.0
5.7
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025315) Body weight
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: RX_L01BB02 – 6-mercaptopurine

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).